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Abstract— The calix[4]arene derivative C-3-nitrophenylcalix[4]resorcinarene was synthesized by using one-pot reaction of 
resorcinol with 3-nitrobenzaldehyde in the presence of concentrated HCl. The compound  was characterized by IR, 1H 
and 13C NMR spectroscopy. X-ray crystallographic study showed that this compound crystallized in a triclinic system 
with space group of Pī and the unit cell dimensions, a = 10.6143(3) Å ,b = 13.6262(4) Å, c = 14.7971(5) Å, α = 102.813(3)°, 
β = 110.917(3)°, γ = 90.885(2)°. V= 1938.78(11) Å3 and Z =2. The biological Studies were also investigated. It has a stromg 
antioxidant property and high antiviral activity against HSV-1 . Cytotoxicity testing on Vero cells showed that it is non-toxic, with a 
CC50 of more than 0.4 mg/mL. Moderate antibacterial activity. 
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I. INTRODUCTION 
Calixarene which was discovered by Adolf Von Baeyer in 
1872 can now be considered as technology materials. The 
supramolecular future with cavitand that can display   host-
guest activity made the calixarene a good candidate as 
absorbant and material for sensor devices [1-5]. Therefore, it 
is not surprising that the development in these two areas of 
application has been quite rapid. In order to improve the 
performance of a device a new design of the active agent 
based on rational design and modelling is carried out before 
attempting the synthesis work. The synthesis work has 
always been the key step to a successful and continuing 
development in the product devdelopment. Calixarene is 
basically  a phenolic macrocycle. Therefore it should display 
antioxidant property.  The biological application of 
calixarene derivatives has currently become an interest to 
many researchers world-wide [6]. One major problem for the 
application in certain field is its low solubility and flexible 
existence of their conformers [7-10]. The presence of more 
than one conformer in the solution can be determined by 
NMR studies. However, in the solid state the 
CALIX[4]resorcinarene  faced stability problem after 
crystallization. Therefore there are relatively less structures 
of the calix have been reported compare to their calix with 
aliphatic linkers.  In this paper the structural study of C-3-
nitrophenylcalix [4]resorcinarene by X-ray crystallography  
and  biological study including antiviral activity are 
presented. 
II. EXPERIMENTAL 
All the compounds utilized in this work were commercially 
available with high purity  purchased from Acros Organics 
(Geel, Belgium) and Sigma-Aldrich (St Louis, MO, USA) 
and were used without further purification. All solvents were 
distilled before use. The microelemental analysis for CHNS-
O was carried out using a Carlo Erba 1108 Elemental 
Analyzer (Milan, Italy). The infrared spectrum (IR) of the 
product (KBr pellets) was recorded using a Perkin Elmer 
Spectrum GX spectrophotometer (Perkin Elmer, Waltham, 
MA, USA) in the range of 400–4,000 cm−1. Nuclear 
Magnetic Resonance (1H and 13C) experiments were 
performed on a Bruker 600 MHz instrument using DMSO-d6 
as the solvent. Single-crystal X-ray experiment was 
performed on Bruker D-QUEST diffractometer  (Bruker, 
AXS Inc., Madison, WI, USA) using graphite-
monochromated Mo-Kα radiation (λ = 0.71073 Å). 
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A. Preparation of  C-3-nitrophenylcalix[4]resorcinarene 
Concentrated hydrochloric acid (7 mL) was added into a 
round-bottom flask containing a solution of 3-
nitrobenzaldehyde (0.01 mol, 1.51 g) in absolute ethanol (60 
mL). The mixture was stirred for 30 minutes and a solution 
of resorcinol (0.01 mol, 1.10 g) in absolute ethanol (20 mL) 
was added. The mixture was refluxed for 24 hours at 80 °C. 
The yellow precipitate formed was collected by filtration, 
washed with distilled water and acetone several times and 
dried under vacuum. Yield (82%); FTIR (KBr, cm−1): 3399 
(OH),1516(C=C), 1313(C-N);1204(C-O),1H-NMR(600 Hz; 
precipitate, DMSO-d6) δH: 4.91 (2H, s, Ar-CH), 5.23 (2H, s, 
Ar-CH), 6.21 (4H, s, Ar-CH),  6.02 (4H, s, Ar-CH), 7.12 
(4H, t, Ar-CH), 7.36 (4H, S, Ar-CH), 7.69 (4H, d, Ar-CH), 
7.76 (4H, d, Ar-CH), 8.92 (4H, s, OH), 9.0 (4H, s, OH); 13C-
NMR (150 MHz; DMSO-d6) δC: 41.9 (4 × CH), 102.4 (4 × 
Ar-H), 119.6 (4 × Ar-CH), 120.5 (4 × Ar-CH), 120.5 (2 × 
Ar-CH),  128.6 (2 × Ar-CH), 129.8 (2 × Ar-H), 133.8 (4 × 
Ar-H), 135.2 (4 × Ar-H), 147.3(4×Ar-CH),153.4(4 × Ar-
OH), 153.7(4 × Ar-OH), 153.9(4 × Ar-NO3). Analysis Calcd 
(%): C = 60.24 and H = 3.50 and N = 5.40. Found (%): C= 
60.12 and H= 3.30 and N = 5.20. 
B.  Cytotoxicity Evaluation 
The cytotoxicity of the compound was first determined on 
uninfected Vero cells (African monkey Cercophiteus aetiops 
kidney cells) with dilutions ranging from 5 mg/mL to 0.039 
mg/mL in Dulbecco’s Modified Eagle’s Medium (DMEM, 
Flowlab, North Ride, Australia). Cytotoxicity was 
determined using the MTT assay [11]. The CC50 value that is 
the compound concentration that kills 50% of the cell 
population was determined by the optical density of 
solubilized formazan. The percentage of growth inhibition 
was calculated using the following formula:  
% Cell viability = 100 × (Abs/Ac), 
where Abs = Absorbance value of test compound and Ac = 
Absorbance value of control (cells only). 
C. Antiviral Activity 
The plaque reduction assay was performed to study the 
presence of antiviral activity of compound. HSV-1 stock was 
prepared and the viral titre of the stock was determined as 
5.7 × 108 pfu/mL. The concentration of compound used in 
this assay was set based on the concentration that allows 
growth of 70% or more Vero cells. This is to ensure that cell 
death is not due to the toxicity of the test compound which 
will affect the accuracy of the test results. In this study, the 
first test concentration of (I) is 0.35 mg/mL, which is below 
the CC50 value and continues with two fold serial dilutions 
until 0.011 mg/mL. Virus was infected to 80% confluent 
cells and incubated for 48 hours for plaque formation. 
Plaques were stained with crystal violet and the numbers of 
plaques were counted. The EC50 value was determined as 
the concentration that inhibited plaque formation by 50% of 
the untreated cells [12]. 
D. Antioxidant Test 
A stock solution of DPPH was prepared by dissolving 
DPPH (0.4 g) in methanol (1 L) and the solution was kept in 
the dark at 4°C. A stock solution of the 3-ntrophenylcalix 
[4]resorcinarene was prepared at 10 mg/5 mL in DMSO. A 
volume of 100 µL from the stock solution of the compound 
was added to 1 mL of DPPH. The mixture was shaken well 
and kept in the dark at room temperature for 2 hours. The 
absorbance of the mixture was measured at 517 nm using a 
spectrophotometer. The percentage of inhibition of radical 
scavenging ability was calculated as: 
Inhibition % = [(ADPPH – ASample)/(ADPPH)] × = [(1.012 − 
0.176)/1.012] × 100 = 82.60%. 
III. RESULTS AND DISCUSSION 
A. Synthesis and Characterization 
The synthesis of C-3-nitrophenylcalix[4]resorcinarene was 
accomplished  by refluxing mixture of equal molar amounts of 
resorcinol with 3-nitrobenzaldehyde in the presence of 
concentrated  HCl  in EtOH at 80 ºC. The FTIR spectrum of the 
compound showed characteristics absorption at 3399 cm-1 
corresponds to O-H stretching vibration. The (C=C) and 
v(C−N) stretching frequencies appeared at 1516 and 1313 
cm-1, respectively. 1H-NMR spectrum of compound showed 
the resorcinol protons appeared at 8.92 and 9.0ppm, 
respectively. The different conformations of calix[4] 
resocinarene can also be observed from the different 
chemical shift of methine linkage protons (4.91 and 5.23 
ppm) indicated that the calix[4]arenes molecule adopts a 
chair conformation. The 13C-NMR spectrum showed the 
carbon chemical shifts of the two sets of the phenolic carbon 
at 153.4 and 153.7ppm. The four tertiary methine carbons 
appeared at 41.9ppm. The aromatic carbon chemical shifts 
appeared in the range of 102.4-153.9 ppm. 
B.  X-Ray Structure 
X-ray investigation showed that the compound 
crystallized in triclinic system with space group of Pĩ. The 
unit cell dimension are a = 10.6143(3) Å, b = 13.6262(4) Å, 
c = 14.7971(5) Å, α = 102.813(3)°, β = 110.917(3)°, γ = 
90.885(2)°. V= 1938.78(11) Å3 and Z =2. The crystal 
system and refinement parameters are given in Table 1. 
 
TABLE 1 
CRYSTALLOGRAPHIC DATA AND STRUCTURAL REFINEMENT OF C-3-
NITROPHENYLCALIX[4]RESORCINARENE 
 
Crystal parameters Data/values 
Empirical formula C60 H62 N4 O25 S4 
Temperature 293(2) K 
Wavelength 1.54178 Å 
Crystal system Triclinic 
Space group Pĩ 
Unit cell dimensions a = 10.6143(3) Å 
b = 13.6262(4) Å 
c = 14.7971(5) Å 
α= 102.813(3)°. 
β= 110.917(3)°. 
γ = 90.885(2)°. 
Volume 1938.78(11) Å3 
Z 2 
Density (calculated) 1.399 Mg/m3 
Absorption coefficient 2.812 mm-1 
2
F(000) 860 
Crystal size 0.40× 0.32 × 0.26 
Theta range for data 
collection 
3.296 to 71.486°. 
Index ranges -13<=h<=13, -16<=k<=16, -
12<=l<=11 
Reflections collected 21497 
Independent reflections 3773 [R(int) = 0.0208] 
Completeness to theta = 
67.679° 
51.5 % 
Refinement method matrix least-squares on F2 
Data / restraints / 
parameters 
3773 / 0 / 498 
Goodness-of-fit on F2 1.045 
Final R indices 
[I>2sigma(I)] 
R1 = 0.0644, wR2 = 0.1570 
R indices (all data) R1 = 0.0668, wR2 = 0.1592 
Extinction coefficient n/a 
Largest diff. peak and 
hole 
1.179 and -1.200 e.Å-3 
 
  The calix molecule adopts a chair conformation (C2h) 
with two opposite resorcinol groups almost coplanar to each 
other and an other pair that are anti-parallel (Figure 1). 
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Figure 1. The molecular structure of C-3-nitro phenyl calix[4]resorcinarene(I). 
The solvent molecules are not shown for clarity. 
 
 The alternate resorcinol rings (C1–C6) and (C14–C19) 
are perpendicular with a dihedral angle of 84.1(3)°. The 
dihedral angle between the resorcinol ring (C1–C6) and 3-
nitrophenyl linkage group (C8–C13) is 87.4(3)°, indicate a 
high degree of co-planarity between the resorcinol rings and 
lead to the adoption of a chair conformation. A similar 
conformation with approximately C2h symmetry due to the 
presence of a crystallographic inversion center has also been 
observed for tetraarylboronic acid resorcinarene [10]. 
 
C. Biological Studies 
 
The cytotoxicity test indicated that C-3-nitrophenylcalix[4] 
resorcinarene is safe to be used as an antimicrobial 
therapeutic agent due to its non-toxicity against Vero cells 
with a CC50 value of 5 mg/mL.mg/mL. The CC50 was 
obtained from the graph of percentage of cell survival 
viability versus compound concentration (Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Percentage of cell survival against concentration of compound that 
C-3-nitrophenylcalix[4] resorcinarene 
 
Antiviral tests showed that the compound  C-3-nitro 
phenyl calix[4]resorcinarene is a good candidate  as an 
antiviral agent because of its ability to inhibit 100% plaque 
formation, even at the lowest concentration of 0.011 mg/mL. 
Thus, the EC50, which is the concentration when the 
presence of test compound caused 50% reduction of plaques 
or cytopathic effect, is much lower than the minimum 
inhibitory concentration of 0.011mg/mL. The selectivity 
index (SI = CC50/EC50) of compound I is more than 36. This 
indicates that compound can be considered as a potentially 
safe antiviral agent with low cytotoxicity and high potency. 
SI values greater than 10 indicate potential antiviral 
therapeutic safety and efficacy. 
Antioxidant properties measured as radical scavenging 
activity are due to the transfer of electrons or hydrogen 
atoms of the hydroxyl groups to an oxidizing agent. 
Compound  being a polyphenolic compound, could inhibit 
the oxidation of other molecules such as 1,1-diphenyl-2-
picryl-hydrazyl (DPPH) by donating hydrogen atoms to 
form the stable non-radical form of DPPH as shown by the 
formation of a pale yellow color. The antioxidant activity 
exhibited by compound  was 82.60%. 
 
IV. CONCLUSIONS 
C-3-nitrophenylcalix[4]resorcinarene was successfully 
synthesized by the cyclocondensation of 3-nitro 
benzaldehyde and resorcinol in the presence of concentrated 
HCl. The X-ray structure was in good agreement with the 
NMR data and the calix molecule adopted a chair C2h 
conformation. The compound showed good anti-HSV-1 and 
antioxidant activity  at non-cytotoxic concentrations. 
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